StonvexLoading…
StonvexStonvexStonvexCore line items from WST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $844.90M | $3.07B | $2.27B | $1.46B |
Operating Income | $177.10M | $584.90M | $428.30M | $260.70M |
Net Income | $138.80M | $493.70M | $361.60M | $131.80M |
EPS (Diluted) | $1.92 | $6.79 | $4.97 | $3.05 |
Total Assets | $4.11B | $4.27B | $4.11B | $3.95B |
Total Liabilities | $1.12B | $1.09B | $1.05B | $1.02B |
Cash & Equivalents | $521.40M | $791.30M | $628.50M | $509.70M |
Free Cash Flow OCF − CapEx | $47.20M | $468.90M | $293.90M | $160.00M |
Shares Outstanding | 70.90M | 72.00M | 71.90M | 71.90M |